Listen

Goals

  • Establish a clear vision for the research program.
  • Develop, refine, and implement methodologies to study pharmacology, toxicology and pharmacotherapy during pregnancy, lactation and in children.
  • Decrease the knowledge gap on pharmacology, toxicology and pharmacotherapy in pregnancy, lactation and in children for selected diseases and medications by adding evidence ranging from pre-clinical to post-marketing studies.
  • Implement new dosing and treatment knowledge in clinical guidelines for pharmacotherapy during pregnancy, lactation and childhood.
  • Facilitate and promote a normative framework for responsible innovation and implementation of pharmacotherapy in pregnancy, lactation and pediatrics.
  • Educate young doctors and researchers on pharmacological and safety issues in these special and vulnerable populations.


go to main content
Research Research programs Obstetric and pediatric clinical pharmacology

Our purpose

To develop a multidisciplinary platform to support and improve evidence-based pharmacotherapy in pregnancy, lactation and pediatrics. To be the go-to research program for questions on obstetric, pediatric clinical pharmacology.

Goals

See some of the most important goals for this research program.

read more

Research groups contributing to this research program

Clinical pharmacy

David Burger's research group uses clinical pharmacology to improve antiviral therapy globally. We focus mainly on HIV. Our main areas of interest are drug-drug interactions, pediatric pharmacology and therapeutic drug monitoring.

Internal medicine

Saskia Middeldorp's research group focuses on venous thromboembolism, and performs clinical and translational research on hereditary and acquired thrombophilia, women’s issues in thrombosis, and the evaluation of new anticoagulants and antidotes.

Obstetrics

Marc Spaanderman's research group aims on improving and maintaining health before, during and after pregnancy by individualized interventions are our research targets.

Spokesperson(s) for this research program

Spokesperson

dr. Marleen van Gelder

contact form